top of page
  • Writer's pictureLouCouPsych

First Returns on Spravato - Success!

Since launching Spravato (intranasal esketamine) treatment at LouCouPsych, there has been genuine excitement and buzz, with great interest in the outcomes. As of this writing, we have 3 patients who have agreed to give feedback and allow publication of their responses to some questions. Dr. Mirza and staff have noticed a tremendous return on investment, with mood and function significantly improving, often quite rapidly. Below is a live and continuously updating graph showing individual responses to treatment over time in weeks against their PHQ-9 scores, a way to objectively quantify depression.

As can be seen, individuals were scoring in the "Moderately-severe" to "Severely" depressed range were down to "Minimal-to-none" within weeks. That is a game changer.

Regarding the experience as a whole, here is a bit more detailed report.

To start your journey with Spravato (intranasal esketamine) for treatment resistant depression, or to learn more, please contact us today!

255 views0 comments

Recent Posts

See All


bottom of page